Key facts
- This page summarizes Mark James Daniel's Form 4 filing for ATOSSA THERAPEUTICS, INC. (ATOS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Mar 2026, 19:22.
Mark James Daniel - 26 Mar 2026 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ATOS
- Reported as of
- 26 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Mar 2026, 19:22:50 UTC
- Prior SEC filing
- 21 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark James Daniel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark James Daniel filed Form 4 for ATOSSA THERAPEUTICS, INC. (ATOS) on 30 Mar 2026.
Change
- Previous filing in this sequence was filed on 21 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002092593
Primary reporting owner
Daniel Mark James
- Relationship
- Chief Financial Officer
- Address
- C/O ATOSSA THERAPEUTICS, INC., 1448 NW MARKET STREET, SUITE 500, SEATTLE
- Signature
- /s/ Mark James Daniel
- Signature date
- 30 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATOS
transaction
Common Stock
Award
- Transaction value
- Shares
- +63,000
- Change %
- Price
- $0.000000*
- Shares after
- 63,000
- Date
- 26 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal annual installments on the first three anniversaries of March 26, 2026.